Medical Program: Unraveling Disease Progression Predictors of mCRC

Unraveling Disease Progression Predictors of mCRC

Unraveling Disease Progression Predictors of mCRC
RestartResume
Disease progression dictates treatment, management, and patient outcomes. But sequencing proves harder than one might think.
  • Overview

    Dr. Benjamin Weinberg, assistant professor at Georgetown University, examines the determinants of disease progression of metastatic colorectal cancer and how these can lead to better approaches to tailored care and personalized management of your patients. 

    Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

     

     

Facebook Comments

NEW FEATURES:

Register

Join the Global Oncology Academy of learners.
Registration is free and easy.

Register Now